cardiac - Nursing Case Study
Pathophysiology
• Primary mechanism: Coronary artery disease - This occurs when the coronary arteries become narrowed or blocked by plaque buildup (atherosclerosis), reducing blood flow to the heart muscle and leading to ischemia or a heart attack.
• Secondary mechanism: Heart failure - The heart becomes weakened and unable to pump blood effectively, often due to damage from a heart attack or chronic hypertension, leading to fluid buildup and inadequate oxygen delivery to tissues.
• Key complication: Arrhythmias - Damage to heart tissue or altered electrical signals can disrupt the heart's rhythm, potentially causing palpitations, dizziness, or even serious conditions like ventricular fibrillation, which can be life-threatening without prompt treatment.
Patient Profile
Demographics:
62 years old, male, retired teacher
History:
• Key past medical history: Hypertension diagnosed 5 years ago, well managed with lifestyle changes
• Current medications: Amlodipine 5 mg daily
• Allergies: No known drug allergies
Current Presentation:
• Chief complaint: Mild chest discomfort during exertion
• Key symptoms: Occasional shortness of breath when climbing stairs, no pain at rest
• Vital signs: Blood pressure 128/82 mmHg, Heart rate 72 bpm, Respiratory rate 18 breaths per minute, Temperature 98.6°F, Oxygen saturation 98% on room air
Section 1
Initial assessment findings reveal that the patient appears well-nourished and in no acute distress. Upon physical examination, his heart sounds are regular with no murmurs or gallops detected. Lung auscultation reveals clear breath sounds bilaterally, suggesting no fluid overload at present. Peripheral pulses are strong and equal, and there is no peripheral edema noted. The patient reports his mild chest discomfort is infrequent and primarily occurs during activities such as brisk walking or climbing stairs. He denies any current shortness of breath at rest, dizziness, or palpitations.
Laboratory tests show his lipid panel results are slightly elevated, with total cholesterol at 210 mg/dL and LDL cholesterol at 135 mg/dL, indicating the need for more aggressive lifestyle modifications or possible medication adjustments. Electrocardiogram (ECG) findings show normal sinus rhythm with no significant ST-segment changes, suggesting stable coronary artery disease without acute ischemia. Given these findings, the healthcare team decides to continue monitoring the patient’s symptoms and considers a stress test to further assess cardiac function under exertion.
The patient's condition remains stable, and the primary focus is on reinforcing lifestyle changes such as diet and exercise, as well as ensuring adherence to current antihypertensive medication. He is advised to monitor his symptoms and report any increase in chest discomfort or onset of new symptoms like dizziness or palpitations. The healthcare team plans to reassess the patient in a few weeks to evaluate the effectiveness of current management strategies and decide if additional interventions are necessary.
Section 2
Two weeks later, the patient returns for a follow-up appointment. During this visit, he reports that he has been adhering to the recommended lifestyle changes, including a diet lower in saturated fats and increased physical activity, such as daily walks. He notes a slight reduction in the frequency of his mild chest discomfort and expresses confidence in managing his condition. He continues to take his prescribed antihypertensive medication regularly.
On physical examination, the patient's vital signs are stable: blood pressure is 128/78 mm Hg, heart rate is 72 beats per minute, respiratory rate is 16 breaths per minute, and oxygen saturation is 98% on room air. Heart sounds remain regular without any new murmurs or gallops, and lung sounds are clear bilaterally. Peripheral pulses are strong and equal, with no evidence of edema. The patient's weight has remained stable, and he appears to be well-nourished and in no distress.
The healthcare team discusses the results of a recent exercise stress test, which shows no significant ischemic changes, indicating that the patient's stable coronary artery disease is well-managed under current conditions. The patient is encouraged to continue his lifestyle modifications and medication adherence. The team reiterates the importance of symptom monitoring and advises the patient to promptly report any new or worsening symptoms. Plans are made for another follow-up in three months to continue monitoring his progress and make any necessary adjustments to his care plan.
Section 3
Three months later, the patient returns for his scheduled follow-up visit. He reports that he has maintained his lifestyle changes and medication regimen, experiencing only occasional mild chest discomfort that resolves with rest. He continues to engage in daily physical activity and has incorporated more fruits, vegetables, and whole grains into his diet. During the visit, the patient mentions a mild, persistent cough that has developed over the past few weeks but denies any shortness of breath or changes in exercise tolerance.
On physical examination, the patient's vital signs are within normal limits: blood pressure is 126/80 mm Hg, heart rate is 70 beats per minute, respiratory rate is 18 breaths per minute, and oxygen saturation is 97% on room air. Heart sounds remain regular without murmurs or gallops, and lung auscultation reveals clear breath sounds bilaterally. A review of the patient's recent lab work reveals stable lipid levels, with a slight improvement in LDL cholesterol, now at 95 mg/dL. However, a complete blood count indicates a mild eosinophilia, prompting the healthcare team to consider the potential for an allergic reaction or other causes of the cough.
The healthcare team discusses the findings with the patient, considering the possibility of a mild side effect from the antihypertensive medication. They decide to monitor the cough closely while encouraging the patient to continue his current regimen. The patient is advised to report any worsening of symptoms or new developments. A follow-up appointment is scheduled in six weeks to reassess the situation and determine if any adjustments to the treatment plan are necessary, ensuring ongoing management of his stable coronary artery disease and overall health.
Section 4
Six weeks later, the patient returns for his scheduled follow-up appointment. He reports that his mild cough has persisted but has not worsened. Additionally, he mentions that he recently experienced a mild rash on his arms and legs, which he attributes to a new laundry detergent. However, upon further questioning, he reveals that the rash appeared before the change in detergent. Despite these minor issues, he continues to adhere to his lifestyle modifications and medication regimen, and he has not experienced any significant changes in his exercise tolerance or chest discomfort.
On this visit, the patient's vital signs remain stable: blood pressure is 124/78 mm Hg, heart rate is 72 beats per minute, respiratory rate is 18 breaths per minute, and oxygen saturation is 98% on room air. Physical examination reveals that the heart sounds continue to be regular with no new murmurs or gallops, and lung auscultation remains clear. The rash is noted to be erythematous and slightly raised but non-pruritic and confined to the arms and legs. The healthcare team decides to conduct further tests, including allergy testing and a comprehensive metabolic panel, to investigate potential causes of the rash and persistent cough.
The results from the allergy testing indicate a mild hypersensitivity reaction, likely related to the patient's current antihypertensive medication. The team discusses the findings with the patient and considers switching to a different class of antihypertensive medication to alleviate these side effects. The patient is counseled on the new medication regimen, and arrangements are made for another follow-up visit in four weeks to monitor the resolution of symptoms and ensure continued management of his stable cardiac condition.
Section 5
At the four-week follow-up visit, the patient reports a noticeable improvement in his symptoms since the change in medication. The mild rash on his arms and legs has completely resolved, and he no longer experiences a persistent cough. He feels encouraged by these changes and continues to adhere to his prescribed lifestyle modifications, including a heart-healthy diet and regular exercise. His energy levels have stayed consistent, and he reports no new symptoms of concern.
During this appointment, the patient's vital signs are taken and remain within normal ranges, reaffirming his stable cardiac condition. His blood pressure is recorded at 122/76 mm Hg, heart rate is 70 beats per minute, respiratory rate is 18 breaths per minute, and oxygen saturation is 99% on room air. A physical examination confirms that his heart sounds are regular with no new murmurs, and lung auscultation remains clear. The absence of the rash and cough suggests a positive response to the medication change.
The healthcare team reviews the results from the comprehensive metabolic panel conducted during the previous visit. The results are unremarkable, showing no signs of metabolic imbalances or liver dysfunction, which further supports the decision to continue with the new antihypertensive medication. Given the patient's positive response and stable condition, the team advises maintaining the current treatment plan. They schedule another follow-up visit in three months to ensure ongoing management of his cardiac health and to monitor for any potential long-term effects of the medication switch. The patient leaves the clinic reassured and motivated to continue his proactive approach to managing his heart health.